Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2019-09-11 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
关于第二大股东非公开发行可交换公司债券获得深圳证券交易所无异议函的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the second largest shareholder's non-public issuance of exchangeable corporate bonds and the receipt of a no-objection letter from the Shenzhen Stock Exchange. It contains no financial statements or detailed financial data, but rather a regulatory update about a financing activity and compliance with disclosure obligations. The document length is only 578 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP).
2019-09-11 Chinese
2019年第一次临时股东大会的法律意见
Regulatory Filings Classification · 90% confidence The document contains only placeholder text indicating omitted pictures and has a very short length (275 characters). There is no substantive content, no financial data, no report title, no regulatory references, or any indication of the document type. Given the lack of content and the presence of only images (omitted), this cannot be classified as a full report or detailed filing. It is likely a placeholder or an announcement-type document with no report content. According to the rules, such minimal content with no report data defaults to Regulatory Filings (RNS).
2019-09-11 Chinese
2019年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2019 first extraordinary general meeting of shareholders of Beijing Shuanglu Pharmaceutical Co., Ltd. It details the meeting date, attendance, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official voting results of shareholder decisions, including approval of capital increase and amendments to the company charter. There is no detailed financial data, management discussion, or full report content. The document is not a full report but an official announcement of voting results from a shareholder meeting. Therefore, it fits the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is under 5,000 characters and it is a formal announcement of voting outcomes, not a report itself.
2019-09-11 Chinese
关于第二大股东新乡白鹭投资集团有限公司股权解除质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the release of pledged shares by the company's second largest shareholder. It details the number of shares released from pledge, the dates, and the proportion of shares involved. There is no financial performance data, no management discussion, no earnings information, or any other report content. The document is a regulatory announcement about share pledge status, which fits best under the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Major Shareholding Notification (MRQ) since it concerns pledge release rather than share ownership threshold changes.
2019-09-11 Chinese
2019年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 半年度财务报告" which translates to "2019 Half-Year Financial Report". It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and equity changes for the period January 1, 2019 to June 30, 2019. The length of the document is substantial (15,000 characters), and it includes actual financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and the content is comprehensive financial reporting for a half-year period. H1 2019
2019-08-26 Chinese
关于召开2019年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2019 first extraordinary general meeting (临时股东大会) of Beijing SL Pharmaceutical Co., Ltd. It details the meeting time, voting methods, attendees, agenda items (including increasing registered capital and amending the articles of association), registration procedures, and proxy voting instructions. It is a formal announcement to shareholders about the meeting and how to participate, not the actual meeting minutes, voting results, or any financial report. The document length is 3517 characters, which is relatively short and consistent with a meeting notice. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes for the meeting.
2019-08-26 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.